Ian R. Friedland
Nessuna posizione attualmente
Profilo
Ian R.
Friedland worked as a Vice President-Clinical Development at Cubist Pharmaceuticals LLC, Senior Director at Johnson & Johnson Pharmaceutical Group, Senior Director at Peninsula Pharmaceuticals, Inc., and Director-Clinical Research at Merck & Co., Inc. He also served as the Chief Medical Officer at Achaogen, Inc. and Calixa Therapeutics, Inc. Dr. Friedland holds a doctorate degree from the University of the Witwatersrand.
Precedenti posizioni note di Ian R. Friedland
Società | Posizione | Fine |
---|---|---|
ACHAOGEN | Direttore Tecnico/Scientifico/R&S | 15/03/2017 |
Calixa Therapeutics, Inc.
Calixa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Calixa Therapeutics, Inc. develops and commercializes hospital-based anti-infective therapies. The company was founded by Eckard Weber and James Ge in 2007 and is headquartered in San Diego, CA. | Direttore Tecnico/Scientifico/R&S | 01/12/2009 |
MERCK & CO., INC. | Corporate Officer/Principal | - |
CUBIST PHARMACEUTICALS INC | Corporate Officer/Principal | - |
Peninsula Pharmaceuticals, Inc.
Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA. | Direttore/Membro del Consiglio | - |
Formazione di Ian R. Friedland
University of the Witwatersrand | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
MERCK & CO., INC. | Health Technology |
Aziende private | 5 |
---|---|
Calixa Therapeutics, Inc.
Calixa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Calixa Therapeutics, Inc. develops and commercializes hospital-based anti-infective therapies. The company was founded by Eckard Weber and James Ge in 2007 and is headquartered in San Diego, CA. | Health Technology |
Johnson & Johnson Pharmaceutical Group | |
Peninsula Pharmaceuticals, Inc.
Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA. | Commercial Services |
Achaogen, Inc.
Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
- Borsa valori
- Insiders
- Ian R. Friedland